1. Abe, T., Kobayashi, K., Nishikawa, S., Yamada, T., Hasegawa, R., Sakuratani, Y., Yamada, J., Hirose, A., Kamata, E., Yoshida, M., Sunouchi, M., Honma, M., Yamashita, T., Sakai, K., Yamazoe, Y. and Hayashi, M. (2012): Development of Hazard Evaluation Support System Database (HESS DB). Pharm stage, 12, 39-47.
2. Astwood, E.B., Bissell, A. and Huges, A.M.C. (1945): Further studies on the chemical nature of compounds which inhibit the function of the thyroid gland. Endocrinology, 37, 456-481.
3. Capen, C.C. (2008): Toxic Responses of the Endocrine System. In: Casarett & Doull’s Toxicology The Basic Science of Poisons 7th edition (Curtis D, Klaassen ed.), pp.807-879. McGraw Hill Medical, New York.
4. Doerge, D.R. (1986): Mechanism-based inhibition of lactoperoxidase by thiocarbamide goitrogens. Biochemistry, 25, 4724-4728.
5. Doerge, D.R. (1988): Mechanism-based inhibition of lactoperoxidase by thiocarbamate goitrogens. Identification of turnover and inactivation pathways. Biochemistry, 27, 3697-3700.